[PDF][PDF] Microsponges as a neoteric cornucopia for drug delivery systems

S Rajeswari, V Swapna - Int J Curr Pharm Res, 2019 - academia.edu
Microsponges (MSPs) are at the forefront of the rapidly developing field of novel drug
delivery systems which are gaining popularity due to their use for controlled release and …

Microsponges enriched gel for enhanced topical delivery of 5-fluorouracil

SK Jain, M Kaur, P Kalyani, A Mehra… - Journal of …, 2019 - Taylor & Francis
This study aimed to develop microsponges based topical gel formulation of 5-Fluorouracil (5-
FU) for the treatment of skin cancer with enhanced skin deposition and reduced skin …

[PDF][PDF] Formulation and characterization of controlled release flurbiprofen microsponges loaded in gels

A Vernekar, R Gude, N Ghadi, S Parab… - Ind. J. Pharm. Edu …, 2019 - academia.edu
Objective: The main objective of this study was to formulate transdermal gels containing
Flurbiprofen microsponges for controlled drug delivery. Methods: Microsponges containing …

A CONCISE LITERATURE REVIEW ON STUDY OF MICROSPONGES FROM ANCIENT TO RECENT.

S Nishal, P Phaugat, R Tushir, M Dhall - Indian Drugs, 2022 - search.ebscohost.com
Polymeric microspheres enclosing an extremely porous surface are termed as
microsponges. Microsponges are drug loaded microporous beads having 10-25 micron …

[PDF][PDF] NOVEL AND INNOVATIVE STRATEGY: MICROSPONGES DRUG DELIVERY SYSTEM.

D Bhanse Najuka, C Shah, D Shah - Pharma Science Monitor, 2016 - pharmasm.com
Microsponges are the rapidly developing field of innovative and novel drug delivery system.
To control the delivery of active ingredients to a specific and pre-determined site of human …

Microsponge: A Innovative Strategy For Drug Delivery System, Current Status And Future Prospects

G Chaitra, VM Vageesh, C Jayanthi… - Pharmacie …, 2017 - search.proquest.com
Microsponge technology has been introduced in topical drug products to facilitate the
controlled release of active drug into the skin in order to reduce systemic exposure and …

[PDF][PDF] REVIEW ON MICROSPONGE LEADING MICROPOROUS PARTICULATE TECHNOLOGY WITH CONTROLLED RELEASE, IMPROVE STABILITY TO PROVIDE …

N Tomar, N Pawar, K Bahmani - researchgate.net
Although serious systemic and cutaneous side effects need a novel delivery system that
provides prolonged and controlled drug release, minimum systemic drug absorption with …

[PDF][PDF] Telmisartan Spongelike Particles as Oral Capsule II: Factors Affecting Formulation

HH Tizkam, AAA Rassol, AA Hussain - Evaluation, 2009 - researchgate.net
Telmisartan (TEL) is selective angiotensin II receptor blocker sued in the management of
cardiovascular disorders. It is a class II drug according to Biopharmaceutics Classification …

[引用][C] Advanced Pharmaceutics

M Mehta, A Panchal, VH Shah, U Upadhyay